Consideration of chemical reaction mechanisms in relationship to the biological action of "dual antagonists".
暂无分享,去创建一个
[1] J. Sokal,et al. Use of AB‐103 (a “dual antagonist”) in the treatment of bronchogenic carcinoma , 1961, Cancer.
[2] A. Segaloff,et al. Clinical Experience with AB‐100: Results of Therapy in 123 Patients , 1961, Southern medical journal.
[3] A. Segaloff,et al. ‘Dual Antagonists’; Alkyl N-(bis-(ethylenimido)phosphoro)-carbamates; a New Series of Anti-Tumour Agents , 1959, Nature.
[4] W. Ross. IN VITRO REACTIONS OF BIOLOGICAL ALKYLATING AGENTS , 1958, Annals of the New York Academy of Sciences.
[5] C. Price. FUNDAMENTAL MECHANISMS OF ALKYLATION , 1958, Annals of the New York Academy of Sciences.
[6] T. Bardos,et al. Synthesis of Deoxyalloxazines (Benzopteridines)1 , 1957 .
[7] E. Allen,et al. Method of Assay for Ethylenimine Derivatives , 1955 .
[8] D. Woolley. Some Aggregate Analogs of p-Aminobenzoic Acid and Dimethyldiaminobenzene Possessing Unusual Biological Properties , 1952 .
[9] W. Ross. 464. The reactions of certain epoxides in aqueous solutions , 1950 .